The validity of using patient self-report to assess psychotic symptoms in schizophrenia

Department of Psychiatry and Biobehavioural Sciences, University of California, Los Angeles, Los Ángeles, California, United States
Schizophrenia Research (Impact Factor: 4.43). 03/2007; 90(1-3):245-50. DOI: 10.1016/j.schres.2006.11.011
Source: PubMed

ABSTRACT Brief, reliable and valid measures of psychosis can be very useful in both clinical practice and research, and for identifying unmet treatment needs in persons with schizophrenia. This study examines the concurrent validity and receiver operating characteristics of the psychosis scale of the Revised Behavior and Symptom Identification Scale (BASIS-R). The study was conducted with 71 adults with schizophrenia who were randomly sampled from a large mental health clinic. Study participants at the West Los Angeles Veterans Healthcare Center were assessed using the BASIS-R, a subjective, self-report measure, and the UCLA Brief Psychiatric Rating Scale (BPRS), a clinician-rated measure administered by highly trained research staff. The psychosis scale of the BASIS-R shows good concurrent validity with the psychosis items on the BPRS. Using the BPRS as the gold standard for measuring psychosis, receiver operating characteristics suggest that both the weighted and unweighted versions of the BASIS-R psychosis scale adequately identify psychosis that is moderate or greater or severe. The performance of the two versions was similar. Unweighted scores are easier to calculate, and we therefore recommend cutoff scores based on the unweighted BASIS-R. We identified a cutoff score of 0.5 to best detect moderate or greater psychosis, and a cutoff score of 1.0 to best detect severe or extremely severe psychosis. The BASIS-R has potential as an assessment tool and screening instrument in schizophrenia.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Simultaneous determination of amphetamine-type stimulants (ATSs), such as methamphetamine (MA), amphetamine (AP), 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA), and p-methoxymethamphetamine (PMMA), has been made for hair of 32 female abusers from different ethnic backgrounds. One milligram of abuser's hair spiked with 1-methyl-3-phenylpropylamine as internal standard was used for each determination of the ATSs. After digestion with 1 M NaOH, the samples were extracted with n-heptane; the organic layer was evaporated to dryness, dissolved in 75 mM of borate buffer solution (pH 8.5), and labeled with 4-(N,N-dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole. The determination of the ATSs in hair was performed by the semi-micro high-performance liquid chromatography-chemiluminescence method. Thirty-two subjects who had self-report histories of ATS use for more than 1 week prior to hair sample collection participated in this study. Concentration ranges of ATSs in abusers’ hair were 0.07–6.73 ng/mg for MA (n = 24), 0.18–2.47 ng/mg for AP (n = 13), 0.05–0.86 ng/mg for MDMA (n = 12), 0.52–1.38 ng/mg for MDA (n = 3), and 0.09–1.88 ng/mg for PMMA (n = 6). Several discrepancies between detected drugs and information obtained from the interviewed abusers were found. Most of the drugs determined in this study could not be detected by the urine test performed at hospitalization. Correlation between ATS concentration and psychiatric symptoms on the basis of Brief Psychiatric Rating Scale (BPRS) was also studied. Simultaneous determination of ATSs in hair of outpatients and inpatients at psychiatric clinics and hospitals should be effective in providing proper diagnosis and treatment. This is the first report to demonstrate the presence of PMMA in hair of human subjects.
    Forensic Toxicology 01/2012; 31(1). DOI:10.1007/s11419-012-0153-6 · 5.76 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous studies point to an association between childhood sexual abuse (CSA) and auditory hallucinations (AH). However, methodological issues limit the strength of these results. Here we compared childhood abuse between psychotic disorder patients and healthy control subjects using a reliable measure of abuse, and assessed the relationship between CSA and AH. 114 psychotic disorder patients and 81 healthy control subjects were administered the Structured Clinical Interview of the DSM-IV (SCID) and the Childhood Trauma Questionnaire (CTQ). We compared the severity of abuse between groups, and tested the relationship between different types of childhood abuse and specific psychotic symptoms. Psychotic patients reported more childhood abuse than controls (p<.001). Psychotic patients with a history of AH reported significantly more sexual, emotional, and physical abuse than patients without a history of AH (p<.05). Emotional and physical abuse, in the absence of sexual abuse, did not lead to a higher rate of AH. Finally, reports of childhood abuse did not increase the risk of any form of hallucination other than AH or of any form of delusion. These results suggest that childhood abuse, especially childhood sexual abuse, shapes the phenotype of psychotic disorders by conferring a specific risk for AH.
    Comprehensive psychiatry 06/2013; DOI:10.1016/j.comppsych.2013.05.013 · 2.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Depressed mood is prevalent among individuals with schizophrenia, leading to difficulties in functioning. Typically, depressed mood is evaluated using retrospective assessments during which individuals are asked to recall their mood during the past week or month. However, as individuals with schizophrenia may display memory difficulties, the results of such assessments may be biased, potentially leading to inaccurate clinical characterizations and/or suboptimal treatment. Our aim was to assess the potential impact of long-term memory on depressed mood in individuals with schizophrenia. Employing an Experience Sampling Method (ESM) approach, 51 individuals with schizophrenia and 22 healthy controls rated their momentary emotions up to 10 times/day over a two-day period, along with retrospective measures of depressed mood, long-term memory, quality of life, social functioning, and symptoms. ESM assessment of real-time depressed mood demonstrated discriminant and convergent validity. Among the schizophrenia group, there was a significant correlation between the real-time and retrospective measures of depressed mood. However, once variance due to long-term memory was controlled, the relationship between the real-time and retrospective measure was no longer significant. The findings suggest that a real-time measure of depressed mood may allow overcoming some of the limitations associated with long-term memory difficulties common among individuals with schizophrenia.
    Psychiatry Research 03/2015; DOI:10.1016/j.psychres.2015.03.008 · 2.68 Impact Factor